NA

Nazir Akbar

Active Director Director DIN 10692188
DIN 10692188 First appointment Jul 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value •••• Premium profile

About Nazir Akbar

Data last updated:

Nazir Akbar is a Director at Safna Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Safna Pharmaceuticals Private Limited reported revenue of ₹7.5 Lakh (FY 2025).

DIN 10692188
Primary Designation Director
Industry Pharma
First Appointment 02 Jul 2024
Oldest Company Age 2 yrs
Largest company Safna Pharmaceuticals Private Limited · ₹7.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Jul 20242024₹7.5 Lakh (FY 2025)Active

Board colleagues of Nazir Akbar

NameDINCompanyDesignation
Sarfaraz Ahmad Farooque10692187Safna Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Safna Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nazir Akbar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nazir Akbar

Nazir Akbar currently holds 1 directorship: Safna Pharmaceuticals Private Limited (Director, since 02 Jul 2024, revenue ₹7.5 Lakh (FY 2025)).

Nazir Akbar was first appointed on 02 Jul 2024 as Director at Safna Pharmaceuticals Private Limited.

The current boards of Nazir Akbar's companies include Sarfaraz Ahmad Farooque (Safna Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available